T5O — bioXXmed AG Cashflow Statement
0.000.00%
Last trade - 00:00- €0.29m
- €0.47m
- €0.02m
Annual cashflow statement for bioXXmed AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.978 | -1.06 | -1.42 | -1.27 | -1.84 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.008 | 0.2 | 0.1 | 0.207 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.007 | -0.126 | -0.07 | 0.245 | -0.047 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.952 | -1.15 | -1.26 | -0.911 | -1.66 |
| Capital Expenditures | -0.07 | -0.004 | -0.01 | -0.014 | -0.003 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.958 | -1.5 | -3.29 | -2.41 | -4.8 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.03 | -1.51 | -3.3 | -2.42 | -4.8 |
| Financing Cash Flow Items | 0 | — | -0.199 | -0.015 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.12 | 3.3 | 5.18 | 2.66 | 6.02 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.86 | 0.645 | 0.627 | -0.678 | -0.44 |